Journal
ACS CHEMICAL NEUROSCIENCE
Volume 2, Issue 12, Pages 705-710Publisher
AMER CHEMICAL SOC
DOI: 10.1021/cn200098p
Keywords
Alzheimer's disease; presenilin; gamma-secretase modulator; GSM-1; click chemistry; photoaffinity labeling
Funding
- NIH [1R01NS076117-01]
- Alzheimer Association [IIRG-08-90824]
- Institutional Training Grant [T32 GM073546-01A1]
Ask authors/readers for more resources
A beta 42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis. gamma-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of A beta 42. However, the binding partner of acid based GSMs was unresolved until now. We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the gamma-secretase complex. Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the gamma-secretase complex leading to the observed modulation of gamma-secretase activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available